Citation

Dutta S. International Journal of Pharmacy and Technology 2015; 6(4): 3067-3107.

Copyright

(Copyright © 2015)

DOI

unavailable

PMID

unavailable

Abstract

Improvement in treatment has led to decreased death in youth with human immunodeficiency virus (HIV) in developed countries. Despite this, youth with HIV are still at risk for increased mortality and morbidity compared with their uninfected counterparts. In developing countries, high numbers of youth die from acquired immune deficiency syndrome (AIDS)-related illnesses due to lack of access to consistent anti retroviral treatment. As a result, pediatric palliative care is a relevant topic for those providing care to youth with HIV. A systematic review was conducted to gather information regarding the status of the literature related to pediatric palliative care and medical decision-making for youth with HIV. This review article focused primarily on physical aspects of care, with less attention paid to psychological, social, ethical, and cultural aspects of care. It recommends that future research focuses on broadening the evaluation of pediatric palliative care among youth with HIV by directly evaluating the psychological, social, ethical, and cultural aspects of care and investigating the needs of all involved stakeholders. © 2015, International Journal Of Pharmacy and Technology. All rights reserved.

Language: en

Keywords

human; age; pediatrics; suicide; systematic review; nephrotoxicity; sex difference; diet; major depression; kidney disease; pathogenesis; disease association; consultation; hospital admission; Human immunodeficiency virus infection; physical examination; neurotoxicity; practice guideline; nonhuman; palliative therapy; edema; drug safety; efavirenz; RNA directed DNA polymerase inhibitor; cardiomyopathy; long term care; patient compliance; acquired immune deficiency syndrome; drug efficacy; breast feeding; congestive heart failure; race difference; neurologic disease; treatment failure; creatinine; Human immunodeficiency virus; immunization; laboratory test; antiretrovirus agent; nevirapine; ritonavir; zidovudine; immune response; central nervous system disease; unspecified side effect; virus resistance; Article; virology; proteinase inhibitor; CD4+ T lymphocyte; lymphocyte count; virus detection; lymphadenopathy; abnormal respiratory sound; atazanavir; interstitial pneumonia; thrush; chronic lung disease; seroprevalence; anthropometry; nonnucleoside reverse transcriptase inhibitor; rilpivirine; darunavir; crackle; staging; dolutegravir; Acquired immune deficiency syndrome; Anti retroviral; chemokine receptor CCR5 antagonist; cobicistat; digital clubbing; elvitegravir; hematopoietic stem cell; kidney examination; lymphoid interstitial pneumonitis; Pediatric palliative care; viral load testing; viral skin disease